Sign Up to like & get
recommendations!
1
Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00601-22
Abstract: Therapeutic options for Mycobacterium abscessus infections are extremely limited, and new drugs are needed. The anti-M. abscessus activity of MRX-6038, ABSTRACT Therapeutic options for Mycobacterium abscessus infections are extremely limited, and new drugs are needed.…
read more here.
Keywords:
mrx 6038;
mrx;
mycobacterium abscessus;
abscessus activity ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.00718-23
Abstract: The antimicrobial activities of four third-generation tetracycline-class drugs, omadacycline (OMC), eravacycline (ERC), tigecycline (TGC), and sarecycline (SAC), were determined for 193 M. abscessus isolates. The activities of the four drugs at two different temperatures (30°C…
read more here.
Keywords:
tgc;
tigecycline;
abscessus activity;
abscessus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2021.779531
Abstract: Therapeutic options for treating Mycobacterium abscessus infections are extremely limited; quinolones are important. The in vitro anti-M. abscessus activities of nine quinolones, emphasizing sitafloxacin, were investigated. Antimicrobial susceptibility testing was performed on 10 non-tuberculous mycobacterium…
read more here.
Keywords:
mycobacterium abscessus;
abscessus activity;
sitafloxacin;
abscessus ... See more keywords